FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model

Sarah R. Mudd, Mark L. Day, David R. Reuter et al.|Cancer Chemotherapy and Pharmacology|2012

Cited by 5